Irish Cancer Society claws back 60% of Daffodil Day loss

After its annual Daffodil Day collection turned into a washout earlier this year, the Irish Cancer Society has clawed back almost two thirds of donation losses from the event.

Irish Cancer Society claws back 60% of Daffodil Day loss

The organisation’s 2012 annual report shows that, last year, the society’s gross income in donations on Daffodil Day fell marginally to €3.2m; expenses of €717,000 reduced the day’s net income to €2.5m.

However, this year’s Daffodil Day event, on Mar 22, was hit by stormy conditions that resulted in donations falling by 50% on 2012.

“Initial shortfalls against the projected amount in the immediate aftermath of the day was 50%,” a spokeswoman said yesterday, adding that this figure now stands at 20%. She attributed this to “an incredibly generous response from members of the public to our Daffodil Day emergency appeal”.

She added: “We have curtailed/deferred some activities in light of Daffodil Day shortfall and other income lines tightening in the recession, while minimising the adverse effects on service provision.”

The society’s report for 2012 shows revenues generated last year fell from €21.9m to €20.7m.

The figures show that the Today FM-supported Shave or Dye campaign raised as much net income as the annual Daffodil Day collection, increasing the net amount raised by 96% to €2.5m.

Two employees earned over €100,000 at the society last year, with chief executive John McCormack receiving a salary of between €125,000 and €150,000. The society has around 148 employees.

“Tthere is general satisfaction about financial performance in 2012,” said the spokeswoman.

The society last year cut its spend from €20.4m to €19.3m. The spokeswoman said: “The society is at all times conscious of cost-effective expenditure and during 2012 savings were achieved without compromising objectives.”

The society last year received €2m in bequests, with the average bequest around €20,000.

Last year, it managed to reduce fundraising costs from €4m to €3.7m through cost savings and changes to campaigns.

The organisation spent €3.5m on cancer research in 2012, had €10.1m in cash, and an additional €5m in investments at year-end.

The report shows that 2,113 patients were given 8,551 nights of nursing care, an increase of 5% for both patients and nights on 2011.

More in this section